Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Ross Stores (ROST) Soars as Q3 2025 Earnings Smash Forecasts and Wall Street Hikes Price Targets

Ross Stores (ROST) Soars as Q3 2025 Earnings Smash Forecasts and Wall Street Hikes Price Targets

Ross Stores stock jumps toward record highs after beating third‑quarter estimates, raising full‑year guidance, and attracting fresh analyst upgrades and institutional buying. Ross Stores (NASDAQ: ROST) is surging on November 21, 2025 after a strong Q3 2025 earnings beat, a
AST SpaceMobile (ASTS) Jumps as BlueBird 6 Launch Date Set and Special Meeting Begins – Key Updates for November 21, 2025

AST SpaceMobile (ASTS) Jumps as BlueBird 6 Launch Date Set and Special Meeting Begins – Key Updates for November 21, 2025

AST SpaceMobile, Inc. (NASDAQ: ASTS) is back in the spotlight today after announcing a firm launch date for its next‑generation BlueBird 6 satellite and convening a special shareholder meeting that could shape how the fast‑growing space‑to‑smartphone company pays its people
Iveda Solutions (IVDA) Stock Soars on New Egyptian 360‑Camera Manufacturing Partnership

Iveda Solutions (IVDA) Stock Soars on New Egyptian 360‑Camera Manufacturing Partnership

Shares of Iveda Solutions, Inc. (NASDAQ: IVDA) ripped higher today after the AI video analytics company announced a tri‑lateral manufacturing partnership in Egypt to locally produce its latest 360‑degree surveillance cameras. iveda.com+1 The deal, which deepens Iveda’s localization strategy in
Veeva Systems (VEEV) Stock Slides After Strong Q3 Earnings and Guidance Raise – What’s Really Spooking Investors on 21 November 2025

Veeva Systems (VEEV) Stock Slides After Strong Q3 Earnings and Guidance Raise – What’s Really Spooking Investors on 21 November 2025

Veeva Systems Inc. (NYSE: VEEV) just delivered another quarter of double‑digit growth and raised its full‑year outlook — yet the stock is tumbling on Friday, 21 November 2025, as Wall Street zeroes in on customer churn in its flagship CRM
Coinbase Stock (COIN) Steadies Near $240 as ETH Loans and Solana Vector Deal Reshape Outlook – November 21, 2025

Coinbase Stock (COIN) Steadies Near $240 as ETH Loans and Solana Vector Deal Reshape Outlook – November 21, 2025

Coinbase Global, Inc. (NASDAQ: COIN) is sitting at the center of another turbulent day for crypto markets and crypto equities. While Bitcoin and Ethereum extend a sharp multi‑day sell‑off, Coinbase is rolling out new ETH‑backed loans, moving deeper into Solana
Opendoor Technologies (OPEN) Stock Tumbles on Warrant Dividend Day as Unsold Homes and Stagnant Housing Market Rattle Investors – November 21, 2025

Opendoor Technologies (OPEN) Stock Tumbles on Warrant Dividend Day as Unsold Homes and Stagnant Housing Market Rattle Investors – November 21, 2025

This article is for informational purposes only and is not investment advice. OPEN stock today: volatility returns to a 2025 high‑flyer Opendoor Technologies Inc. (NASDAQ: OPEN) is back in the spotlight this Friday, November 21, as its shares swing sharply
21 November 2025
Elastic (ESTC) Stock Slides After Strong Q2 FY26 Beat as Wall Street Resets AI Hopes

Elastic (ESTC) Stock Slides After Strong Q2 FY26 Beat as Wall Street Resets AI Hopes

Elastic N.V. (NYSE: ESTC), the “Search AI Company,” is under heavy pressure in Friday trading despite delivering better‑than‑expected fiscal second‑quarter 2026 results, raising full‑year guidance and leaning harder into generative AI and cloud growth. After reporting earnings on Thursday evening,
Metsera (MTSR) News Today, 21 November 2025: Pfizer’s $10 Billion Buyout, $6 Billion Bond Sale and What It Means for Investors

Metsera (MTSR) News Today, 21 November 2025: Pfizer’s $10 Billion Buyout, $6 Billion Bond Sale and What It Means for Investors

Pfizer has closed its up to $10 billion acquisition of Metsera (MTSR) and raised $6 billion in bonds to help fund the deal. Here’s what today’s developments mean for former Metsera shareholders, Pfizer investors and the future of the obesity
1 5 6 7 8 9 216
Go toTop